These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21041506)

  • 1. In vitro activity of ceftaroline against a broad spectrum of recent clinical anaerobic isolates.
    Snydman DR; Jacobus NV; McDermott LA
    Antimicrob Agents Chemother; 2011 Jan; 55(1):421-5. PubMed ID: 21041506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients.
    Edmiston CE; Krepel CJ; Kehl KS; Seabrook GR; Somberg LB; Almassi GH; Smith TL; Loehrl TA; Brown KR; Lewis BD; Towne JB
    J Antimicrob Chemother; 2005 Nov; 56(5):872-8. PubMed ID: 16186167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates.
    Speciale A; Musumeci R; Blandino G; Milazzo I; Caccamo F; Nicoletti G
    Int J Antimicrob Agents; 2002 Feb; 19(2):111-8. PubMed ID: 11850163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and beta-lactams.
    Behra-Miellet J; Dubreuil L; Jumas-Bilak E
    Int J Antimicrob Agents; 2002 Nov; 20(5):366-74. PubMed ID: 12431872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteria.
    Edlund C; Sabouri S; Nord CE
    Eur J Clin Microbiol Infect Dis; 1998 Mar; 17(3):193-5. PubMed ID: 9665302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of moxifloxacin and tigecycline against bacterial isolates associated with intraabdominal infections at a medical center in Taiwan, 2001-2006.
    Liu CY; Lu CL; Huang YT; Liao CH; Hsueh PR
    Eur J Clin Microbiol Infect Dis; 2009 Dec; 28(12):1437-42. PubMed ID: 19763644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activities of moxifloxacin against 900 aerobic and anaerobic surgical isolates from patients with intra-abdominal and diabetic foot infections.
    Edmiston CE; Krepel CJ; Seabrook GR; Somberg LR; Nakeeb A; Cambria RA; Towne JB
    Antimicrob Agents Chemother; 2004 Mar; 48(3):1012-6. PubMed ID: 14982797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of ceftaroline against 623 diverse strains of anaerobic bacteria.
    Citron DM; Tyrrell KL; Merriam CV; Goldstein EJ
    Antimicrob Agents Chemother; 2010 Apr; 54(4):1627-32. PubMed ID: 20100877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility patterns for recent clinical isolates of anaerobic bacteria in South Korea.
    Lee Y; Park Y; Kim MS; Yong D; Jeong SH; Lee K; Chong Y
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3993-7. PubMed ID: 20585132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
    Goldstein EJ; Citron DM; Cherubin CE; Hillier SL
    J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of tigecycline and comparators against a European collection of anaerobes collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2010-2016.
    Rodloff AC; Dowzicky MJ
    Anaerobe; 2018 Jun; 51():78-88. PubMed ID: 29679648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative anti-anaerobic activity of Men 10700, a penem antibiotic.
    Hamilton-Miller JM; Shah S
    Int J Antimicrob Agents; 1998 Nov; 10(4):321-4. PubMed ID: 9916909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moxifloxacin resistance is prevalent among Bacteroides and Prevotella species in Greece.
    Papaparaskevas J; Pantazatou A; Katsandri A; Houhoula DP; Legakis NJ; Tsakris A; Avlamis A
    J Antimicrob Chemother; 2008 Jul; 62(1):137-41. PubMed ID: 18385145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The growth-inhibitory properties of meropenem against anaerobes of clinical importance.
    Watt B; Naden M
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():119-24. PubMed ID: 2808203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of tigecycline against recently isolated Gram-negative anaerobic bacteria in Greece, including metronidazole-resistant strains.
    Katsandri A; Avlamis A; Pantazatou A; Petrikkos GL; Legakis NJ; Papaparaskevas J;
    Diagn Microbiol Infect Dis; 2006 Jul; 55(3):231-6. PubMed ID: 16626904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007.
    Yang JC; Lee PI; Hsueh PR
    Eur J Clin Microbiol Infect Dis; 2010 Nov; 29(11):1369-75. PubMed ID: 20658256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic efficacy of moxifloxacin, a new quinolone, in the treatment of experimental intra-abdominal abscesses induced by Bacteroides fragilis in mice.
    Thadepalli H; Chuah SK; Gollapudi S
    Chemotherapy; 2004 Jun; 50(2):76-80. PubMed ID: 15211081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of endometrial isolates recovered from women with clinical pelvic inflammatory disease or histological endometritis to antimicrobial agents.
    Petrina MAB; Cosentino LA; Wiesenfeld HC; Darville T; Hillier SL
    Anaerobe; 2019 Apr; 56():61-65. PubMed ID: 30753898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of moxifloxacin on bacterial pathogenicity factors in comparison with amoxicillin, clarithromycin and ceftriaxone.
    Drago L; De Vecchi E; Nicola L; Tocalli L; Gismondo MR
    J Chemother; 2004 Feb; 16(1):30-7. PubMed ID: 15077996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of tigecycline and comparators against organisms associated with intra-abdominal infections collected as part of TEST (2004-2009).
    Mayne D; Dowzicky MJ
    Diagn Microbiol Infect Dis; 2012 Oct; 74(2):151-7. PubMed ID: 22770774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.